|Rs in Crore||Sep-20||Sep-19||YOY||Jun-20||QOQ|
|Profit After Tax (PAT)||519.59||356.78||45.63%||492.06||5.59%|
|Diluted EPS (Rs)||₹ 19.57||₹ 13.44||₹ 18.51|
Key takeaways from the Sep-20 quarter results
- The last few quarters have been extremely strong for the active pharma ingredients or API business which Divi’s specializes in. This segment showed strong demand as an alternative to China and also prices went up sharply as pharma companies across the world started to stock up on APIs.
- The net cash flow generated from operations was up nearly 3-fold yoy at Rs1,157cr in H1 on the back of higher pre-tax profits and better working capital flows.